Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 3, 2007, Pages 1064-1070

  Eksi, S ^a   Czesny, B ^a   Van Gemert, G J ^b   Sauerwein, R W ^b   Eling, W ^b   Williamson, K C ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN; ANTIMALARIAL AGENT; CYSTEINE; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; FALCIPAIN 2; FALCIPAIN 3; HEMOGLOBIN; MEMBRANE ANTIGEN; PAPAIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ERYTHROCYTE; FLAGELLUM; GAMETOCYTE; GAMETOGENESIS; HOST; MALARIA; NONHUMAN; NUTRIENT; OOCYST; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPOROGENESIS;

ANIMALS; ANTIMALARIALS; CULICIDAE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ERYTHROCYTES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GAMETOGENESIS; HUMANS; IMMUNOBLOTTING; LEUCINE; OOCYSTS; PLASMODIUM FALCIPARUM;

EID: 33847650902     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01012-06     Document Type: Article

References (39)

1. Aly, A. S., and K. Matuschewski. 2005. A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts. J. Exp. Med. 202:225-230.
2. Barnes, K. I., and N. J. White. 2005. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop. 94:230-240.
3. Brooks, S., and K. C. Williamson. 2000. Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis. Mol. Biochem. Parasitol. 106:77-82.
4. Coppi, A., C. Pinzon-Ortiz, C. Hutter, and P. Sinnis. 2005. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J. Exp. Med. 201:27-33.
5. Desai, P. V., A. Patny, J. Gut, P. J. Rosenthal, B. Tekwani, A. Srivastava, and M. Avery. 2006. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. J. Med. Chem. 49:1576-1584.
6. Dhawan, S., M. Dua, A. H. Chishti, and M. Hanspal. 2003. Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells. J. Biol. Chem. 278:30180-30186.
7. Dua, M., P. Raphael, P. S. Sijwali, P. J. Rosenthal, and M. Hanspal. 2001. Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1. Mol. Biochem. Parasitol. 116:95-99.
8. Eksi, S., B. Czesny, D. C. Greenbaum, M. Bogyo, and K. C. Williamson. 2004. Targeted gene disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth. Mol. Microbiol. 53:243-250.
9. Eksi, S., B. Czesny, G. J. van Gemert, R. W. Sauerwein, W. Eling, and K. C. Williamson. 2006. Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production. Mol. Microbiol. 61:991-998.
10. Greenbaum, D. C., A. Baruch, M. Grainger, Z. Bozdech, K. F. Medzihradszky, J. Engel, J. DeRisi, A. A. Holder, and M. Bogyo. 2002. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298:2002-2006.
11. Hanspal, M., M. Dua, Y. Takakuwa, A. H. Chishti, and A. Mizuno. 2002. Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100:1048-1054.
12. Hogh, B., A. Gamage-Mendis, G. A. Butcher, R. Thompson, K. Begtrup, C. Mendis, S. M. Enosse, M. Dgedge, J. Barreto, W. Eling, and R. E. Sinden. 1998. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am. J. Trop. Med. Hyg. 58:176-182.
13. Ifediba, T., and J. P. Vanderberg. 1981. Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature 294:364-366.
14. Lang-Unnasch, N., and A. D. Murphy. 1998. Metabolic changes of the malaria parasite during the transition from the human to the mosquito host. Annu. Rev. Microbiol. 52:561-590.
15. Mair, G. R., J. A. Braks, L. S. Garver, J. C. Wiegant, N. Hall, R. W. Dirks, S. M. Khan, G. Dimopoulos, C. J. Janse, and A. P. Waters. 2006. Regulation of sexual development of Plasmodium by translational repression. Science 313:667-669.
16. Micale, N., A. P. Kozikowski, R. Ettari, S. Grasso, M. Zappala, J. J. Jeong, A. Kumar, M. Hanspal, and A. H. Chishti. 2006. Novel pcptidomimetic cysteine protease inhibitors as potential antimalarial agents. J. Med. Chem. 49:3064-3067.
17. Na, B. K., B. R. Shenai, P. S. Sijwali, Y. Choe, K. C. Pandey, A. Singh, C. S. Craik, and P. J. Rosenthal. 2004. Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax. Biochem. J. 378:529-538.
18. Nielsen, K. M., J. Kasper, M. Choi, T. Bedford, K. Kristiansen, D. F. Wirth, S. K. Volkman, E. R. Lozovsky, and D. L. Hartl. 2003. Gene conversion as a source of nucleotide diversity in Plasmodium falciparum. Mol. Biol. Evol. 20:726-734.
19. Ponnudurai, T., A. H. Lensen, A. D. Leeuwenberg, and J. H. Meuwissen. 1982. Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. I. Static cultures. Trans. R. Soc. Trop. Med. Hyg. 76:812-818.
20. Ponnudurai, T., A. H. Lensen, G. J. Van Gemert, M. P. Bensink, M. Bolmer, and J. H. Meuwissen. 1989. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology 98(Pt 2):165-173.
21. Puta, C., and C. Manyando. 1997. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Trop. Med. Int. Health 2:227-229.
22. Ramjee, M. K., N. S. Flinn, T. P. Pemberton, M. Quibell, Y. Wang, and J. P. Watts. 2006. Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery. Biochem. J. 399:47-57.
23. Raphael, P., Y. Takakuwa, S. Manno, S. C. Liu, A. H. Chishti, and M. Hanspal. 2000. A cysteine protease activity from Plasmodium falciparum cleaves human erythrocyte ankyrin. Mol. Biochem. Parasitol. 110:259-272.
24. Riley, E. M., K. C. Williamson, B. M. Greenwood, and D. C. Kaslow. 1995. Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230. Parasite Immunol. 17:11-19.
25. Rosenthal, P. J., J. H. McKerrow, M. Aikawa, H. Nagasawa, and J. H. Leech. 1988. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Investig. 82:1560-1566.
26. Rosenthal, P. J., and R. G. Nelson. 1992. Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. Mol. Biochem. Parasitol. 51:143-152.
27. Rosenthal, P. J., P. S. Sijwali, A. Singh, and B. R. Shenai. 2002. Cysteine proteases of malaria parasites: targets for chemotherapy. Curr. Pharm. Design 8:1659-1672.
28. Salmon, B. L., A. Oksman, and D. E. Goldberg. 2001. Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc. Natl. Acad. Sci. USA 98:271-276.
29. Shenai, B. R., B. J. Lee, A. Alvarez-Hernandez, P. Y. Chong, C. D. Emal, R. J. Neitz, W. R. Roush, and P. J. Rosenthal. 2003. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrob. Agents Chemother. 47:154-160.
30. Shenai, B. R., A. V. Semenov, and P. J. Rosenthal. 2002. Stage-specific antimalarial activity of cysteine protease inhibitors. Biol. Chem. 383:843-847.
31. Shenai, B. R., P. S. Sywali, A. Singh, and P. J. Rosenthal. 2000. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem. 275:29000-29010.
32. Sijwali, P. S., J. Koo, N. Singh, and P. Rosenthal. 2006. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Mol. Biochem. Parasitol. 150:96-106.
33. Sijwali, P. S., and P. J. Rosenthal. 2004. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 101:4384-4389.
34. Sijwali, P. S., B. R. Shenai, J. Gut, A. Singh, and P. J. Rosenthal. 2001. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem. J. 360:481-489.
35. Singh, N., P. S. Sijwali, K. C. Pandey, and P. J. Rosenthal. 2006. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2′. Exp. Parasitol. 112:187-192.
36. von Seidlein, L., M. Jawara, R. Coleman, T. Doherty, G. Walraven, and G. Targett. 2001. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop. Med. Int. Health 6:92-98.
37. Wickham, M. E., J. G. Culvenor, and A. F. Cowman. 2003. Selective inhibition of a two-step egress of malaria parasites from the host erythrocyte. J. Biol. Chem. 278:37658-37663.
38. Williamson, K. C., D. B. Keister, O. Muratova, and D. C. Kaslow. 1995. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes. Mol. Biochem. Parasitol. 75:33-42.
39. Young, J. A., Q. L. Fivelman, P. L. Blair, P. de la Vega, K. G. Le Roch, Y. Zhou, D. J. Carucci, D. A. Baker, and E. A. Winzeler. 2005. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification. Mol. Biochem. Parasitol. 143:67-79.